Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy of a delightful breeze and shiny sun hovering over the peaceful Pharmalot campus this morning. Our shortest person has left for the local schoolhouse, another short one has left for remunerative activities, and our official mascot has settled down after barking at passersby. This leaves us all alone to forage for interesting items and speak with interesting people. Meanwhile, here is the usual menu of tidbits. Hope your day goes well and do keep us in mind when something interesting pops …

A $270 million settlement between the state of Oklahoma and Purdue Pharma, which was praised last week as an innovative way to help combat opioid addiction, is facing bipartisan criticism from state lawmakers who say the attorney general overstepped his authority, the Associated Press writes. Lawmakers say money from the first-of-its-kind settlement should have gone to the state treasury, where legislators would have determined how it was spent. They also grumbled that Attorney General Mike Hunter kept them in the dark about settlement talks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy